key: cord-0694096-nowk0y7w authors: Xiao, Ai Tang; Tong, Yi Xin; Zhang, Sheng title: False‐negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence date: 2020-04-09 journal: J Med Virol DOI: 10.1002/jmv.25855 sha: ce9ee8e32ade4ce6d74212ece5d30ad32211615f doc_id: 694096 cord_uid: nowk0y7w A novel coronavirus (COVID‐19) pandemic cause by Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) threatens the world. We read with interest the recent report by Li et al. that included 610 patients with Coronavirus Disease 2019 (COVID‐19). They reported a high false‐negative rate of real‐time reverse transcription polymerase chain reaction (RT‐PCR) results for SARS‐CoV‐2 detection. In addition, recent report regarding SARS‐CoV‐2 “turn positive” in recovered cases with COVID‐19 were published. Here, we studied the characteristics of nucleic acid conversion for SARS‐CoV‐2 from 70 COVID‐19 patients. We found that 15 (21.4%) patients experienced a “turn positive” of nucleic acid detection by RT‐PCR test for SARS‐CoV‐2 after two consecutive negative results, which may be related to the false negative of RT‐PCR test and prolonged nucleic acid conversion This article is protected by copyright. All rights reserved. detection. In addition, recent report regarding SARS-CoV-2 "turn positive" in recovered cases with COVID-19 were published. 2 Here, we studied the characteristics of nucleic acid conversion for SARS-CoV-2 from 70 COVID-19 patients. We found that 15 (21.4%) patients experienced a "turn positive" of nucleic acid detection by RT-PCR test for SARS-CoV-2 after two consecutive negative results, which may be related to the false negative of RT-PCR test and prolonged nucleic acid conversion. A total of 70 patients (admission date from Jan 21 st to Feb 12 th , 2020) with confirmed SARS-CoV-2 infection at Tongji Hospital in Wuhan were included in this study. Throat swab samples or deep nasal cavity swab samples were collected from patients on different dates after the onset of symptoms. SARS-CoV-2 were detected by RT-PCR assay using a COVID-19 nucleic acid detection kit according to the manufacturer's protocol (Shanghai Huirui Biotechnology Co., Ltd). 3 According to the current guideline, all included patients were mild to moderate 4 . No patient was transferred to ICU. Nucleic acid conversion time is defined as the period from the date of symptoms onset to the date of first negative RT-PCR test result (In some cases, patients got positive RT-PCR results following false negative results, which were considered non-effective negative results in our study). Our This article is protected by copyright. All rights reserved. The pandemic of COVID-19 threatened the whole world with more than 1,000,000 infected cases. Evidence suggested that the outbreaks of COVID-19 may be correlated to its rapid person-to-person transmission ability. 5 Since specific treatment had not been validated for COVID-19, traditional public health tacticsisolation, quarantine and community containment are critical to control the spread. This article is protected by copyright. All rights reserved. We thank Ms. Cheng Chen for English grammatic correction of this manuscript. All authors have agreed on the final version and meet the major criteria recommended by the ICMJE (http://www.icmje.org/) Funding No funding resources to declare for this study. All authors declare that there are no conflicts of interest. Hospital, Tongji Medical College, Huazhong University of Science and Technology. All procedures followed in this study were in accordance with the 1964 Helsinki Declaration and later versions. Informed consent Oral consent was obtained from patients involved before enrollment when data were collected retrospectively. The database used and/or analyzed during the current study is not publicly available (to maintain privacy) but can be available from the corresponding author on reasonable request. For p-value: Boldface type indicates significant difference. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19 SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge Profile of Specific Antibodies to SARS-CoV-2: The First Report Diagnosis and treatment of 2019-nCoV pneumonia in China. (Version 5) In Chinese Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention